Clinical Trial Update: A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the safety of intravitreal aflibercept in Indian participants with diabetic macular edema; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2025-09-04